CellMax Life competitors

CellMax Life's competitors include Magenta Therapeutics, Cord Blood America, Clementia Pharmaceuticals and International Stem Cell Corporation
Add company...
CellMax Life
CellMax Life is a biotechnology company that is focused on developments in early cancer detection and prevention.
Magenta Therapeutics
Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases.
Cord Blood America
Cord Blood America, Inc. provides cord blood and cord tissue stem cell services.
Clementia Pharmaceuticals
Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.
International Stem Cell Corporation
International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products.
Founding Date
Founding Date
2013
Founding Date
2016
Founding Date
1999
Founding Date
2012
Founding Date
2001
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Sunnyvale, US HQ
Songshan District, TW
Locations
Cambridge, US HQ
Locations
Las Vegas, US HQ
Locations
Westmount, CA HQ
Newton, US
Locations
Carlsbad, US HQ
Employees
Employees
389% increase
Employees
578% increase
Employees
15
Employees
455% increase
Employees
41
Valuation ($)
Valuation ($)
N/A
Valuation ($)
453.3 m
Valuation ($)
3.7 m
Valuation ($)
N/A
Valuation ($)
6.7 m
Twitter followers
Twitter followers
47
Twitter followers
694
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
10.1 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$3.3m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$7.2b (FY, 2016)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$904.9k (FY, 2016)
Cost of goods
N/A
Cost of goods
$1.9b (FY, 2016)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$2.4m (FY, 2016)
Gross profit
N/A
Gross profit
$5.2b (FY, 2016)
Net income
Net income
N/A
Net income
N/A
Net income
$102.2k (FY, 2016)
Net income
($57.5m) (FY, 2016)
Net income
($1.1b) (FY, 2016)

Funding

Latest funding round
Latest funding round
$ 5m (about 5 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 60m (about 3 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 5m
Total funding raised
$ 150.5m
Total funding raised
N/A
Total funding raised
$ 92.5m
Total funding raised
$ 2.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Magenta Therapeutics
HQ
Cambridge, US
Employees
57↑ 8% increase

Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases.

View company
Cord Blood America
HQ
Las Vegas, US
Employees
15

Cord Blood America, Inc. provides cord blood and cord tissue stem cell services.

View company
Clementia Pharmaceuticals
HQ
Westmount, CA
Employees
45↑ 5% increase

Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.

View company
International Stem Cell Corporation
HQ
Carlsbad, US
Employees
41

International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products.

View company